D

Aclaris Therapeutics, Inc. ACRS

$3.44 -$0.06-1.71% NASDAQ
Recommendation
Dividend Power Score
Day's Range
$3.40$3.55
Latest Close
Volume
Avg Vol (90D)
Market Cap
Dividend & Yield
--
P/E (TTM)
--
EPS (TTM)
My Lists My Alerts
Access our Premium Ratings
Get Access

ACRS Rating

Reward
Risk

ACRS Rating Factors

Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Yield Index

ACRS Company Overview

Aclaris Therapeutics, Inc. is a U.S.-based biopharmaceutical company focused on developing immuno-inflammatory therapies and specialty dermatology treatments. The company operates primarily in the biotechnology and pharmaceutical industries, with an emphasis on small-molecule and kinase inhibitor therapies targeting immune-mediated diseases. Historically, Aclaris generated revenue from commercial dermatology products, but in recent years it has shifted toward a development-stage biotechnology model centered on immunology and inflammation-focused drug candidates.

The company’s primary business lines include research and development of oral and topical therapeutics, particularly kinase inhibitors targeting pathways associated with inflammatory and autoimmune conditions. Aclaris has pursued indications in dermatology, rheumatology, and immunology, including alopecia areata and atopic dermatitis. The company was founded in 2012 and expanded initially through acquisitions and commercialization of dermatology products before restructuring its portfolio to prioritize pipeline development and strategic partnerships. Its positioning has been supported by internal drug discovery capabilities and expertise in kinase biology.

Data compiled by narrative technology. May contain errors.
Sector

ACRS Income Statement

Total Revenue (TTM)
EBITDA (TTM)
EBIT (TTM)
Net Income (TTM)

ACRS Balance Sheet

Total Assets (Q)
Total Debt (Q)
Total Liabilities (Q)
Book Value Per Share (Q)

ACRS Cash Flow

Cash from Operations (TTM)
Cash from Investing (TTM)
Cash from Financing (TTM)
Net Change in Cash (TTM)

ACRS Price History

Loading...
52-Week Range26% of range
Current
$3.44
Beta
7-Day Total Return
30-Day Total Return
60-Day Total Return
90-Day Total Return
Year to Date Total Return
1-Year Total Return
2-Year Total Return
3-Year Total Return
5-Year Total Return

ACRS Valuation

Market Cap
Market Cap Rank
#7,781
Enterprise Value
Price/Sales (TTM)
Price/Book (Q)

ACRS Dividends and Shares

Shares Outstanding
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--

ACRS Corporate Info

Phone Number
484 324 7933
Address
701 Lee Road
Suite 103
Wayne, PA 19087
Country
Year Founded

ACRS Filings

Filing Date
Thursday, November 5, 2026
Period Date
Wednesday, September 30, 2026
Next Filing
Week of Feb 22 and 26 (est)

ACRS Headlines